Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
(2018)
Journal Article
Jankowski, J. A., de Caestecker, J., Love, S. B., Reilly, G., Watson, P., Sanders, S., …Moayyedi, P. (2018). Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. Lancet, 392(10145), 400-408. https://doi.org/10.1016/S0140-6736%2818%2931388-6
Background: Oesophageal adenocarcinoma (OA) is the sixth commonest cause of cancer death worldwide and Barrett’s oesophagus (BO) is the most significant risk factor. We evaluated the efficacy of high-dose esomeprazole proton pump inhibitor acid suppr... Read More about Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.